Literature DB >> 17961284

Evaluation of an in vitro and in vivo model for experimental infection with Leishmania (Viannia) braziliensis and L. (V.) peruviana.

D Gamboa1, K Torres, S De Doncker, M Zimic, J Arevalo, J-C Dujardin.   

Abstract

Leishmania (Viannia) braziliensis and L. (V.) peruviana are two parasite species characterized by a very different pathogenicity in humans despite a high genetic similarity. We hypothesized previously that L. (V.) peruviana would descend from L. (V.) braziliensis and would have acquired its 'peruviana' character during the southward colonization and adaptation of the transmission cycle in the Peruvian Andes. In order to have a first appreciation of the differences in virulence between both species, we evaluated an in vitro and in vivo model for experimental infection. A procedure was adapted to enrich culture forms in infective stages and the purified metacyclics were used to infect macrophage cell lines and golden hamsters. The models were tested with 2 representative strains of L. (V.) braziliensis from cutaneous and mucosal origin respectively and 2 representative strains of L. (V.) peruviana from Northern and Southern Peru respectively. Our models were reproducible and sensitive enough to detect phenotypic differences among strains. We showed in vitro as well as in vivo that the L. (V.) braziliensis was more infective than L. (V.) peruviana. Furthermore, we found that in vitro infectivity patterns of the 4 strains analysed, were in agreement with the geographical structuring of parasite populations demonstrated in our previous studies. Further work is needed to confirm our results with more strains of different geographical origin and their specific clinical outcome. However, our data open new perspectives for understanding the process of speciation in Leishmania and its implications in terms of pathogenicity.

Entities:  

Mesh:

Year:  2007        PMID: 17961284     DOI: 10.1017/S0031182007003848

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  7 in total

1.  Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations.

Authors:  Raquel P Ribeiro-Romão; Otacílio C Moreira; Elvia Yaneth Osorio; Lea Cysne-Finkelstein; Adriano Gomes-Silva; Joanna G Valverde; Claude Pirmez; Alda Maria Da-Cruz; Eduardo Fonseca Pinto
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

2.  BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.

Authors:  Diego L Costa; Vanessa Carregaro; Djalma S Lima-Júnior; Neide M Silva; Cristiane M Milanezi; Cristina R Cardoso; Ângela Giudice; Amélia R de Jesus; Edgar M Carvalho; Roque P Almeida; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2011-03-01

3.  Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates.

Authors:  Vanessa Adaui; Denis Castillo; Mirko Zimic; Andres Gutierrez; Saskia Decuypere; Manu Vanaerschot; Simonne De Doncker; Kathy Schnorbusch; Ilse Maes; Gert Van der Auwera; Louis Maes; Alejandro Llanos-Cuentas; Jorge Arevalo; Jean-Claude Dujardin
Journal:  PLoS Negl Trop Dis       Date:  2011-05-10

4.  In vitro metacyclogenesis of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis clinical field isolates, as evaluated by morphology, complement resistance, and infectivity to human macrophages.

Authors:  Ildefonso Alves da Silva; Camila Imai Morato; Valéria Bernadete Leite Quixabeira; Ledice Inácia de Araújo Pereira; Miriam Leandro Dorta; Milton Adriano Pelli de Oliveira; Maria Fátima Horta; Fátima Ribeiro-Dias
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

5.  Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered In Vivo Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis.

Authors:  Diana Caridha; Sandi Parriot; Thomas H Hudson; Thierry Lang; Franklyn Ngundam; Susan Leed; Jenell Sena; Michael Harris; Michael O'Neil; Richard Sciotti; Lisa Read; Herve Lecoeur; Mark Hickman; Max Grogl
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 6.  Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis.

Authors:  Diana Caridha; Brian Vesely; Katrien van Bocxlaer; Byron Arana; Charles E Mowbray; Sima Rafati; Silvia Uliana; Rosa Reguera; Mara Kreishman-Deitrick; Richard Sciotti; Pierre Buffet; Simon L Croft
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-06-20       Impact factor: 4.077

7.  Stimulation of metacyclogenesis in Leishmania (Mundinia) orientalis for mass production of metacyclic promastigotes.

Authors:  Wetpisit Chanmol; Narissara Jariyapan; Kanok Preativatanyou; Chonlada Mano; Pongsri Tippawangkosol; Pradya Somboon; Paul A Bates
Journal:  Front Cell Infect Microbiol       Date:  2022-09-05       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.